Cases & Deals

Sanofi defends proposed class action alleging conspiracy to raise prices

Clients Sanofi-Aventis U.S. LLC

Jones Day is defending Sanofi-Aventis U.S. LLC against a proposed class action alleging that the company conspired with or through pharmacy benefit managers to raise prices for its diabetes drug, Lantus, in violation of federal and state antitrust, consumer protection, fraud, RICO, and employee benefit laws.

Chaires v. Novo Nordisk Inc., No. 17-cv-00699 (D.N.J.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.